Monoclonal Gammopathy
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance (NCT04614558) | Columbia University | 2021-06-08 |
| Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy (NCT03832140) | University Hospital, Brest | 2019-05-24 |
| Rifaximin in Patients With Monoclonal Gammopathy (NCT03820817) | Emory University | 2019-05-15 |
| Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma (NCT03236428) | Dana-Farber Cancer Institute | 2017-11-24 |
| A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early (NCT02741999) | Tufts Medical Center | 2016-04-01 |
| Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy (NCT01543100) | Rennes University Hospital | 2010-11-01 |
| Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis (NCT00173264) | National Taiwan University Hospital | 2005-06-01 |
Track Monoclonal Gammopathy automatically
Every clearance here is in the API, with alerts when new ones post.